Articles tagged with Molecular Imaging
A new type of microscopy developed by Xiaowei Zhuang at Harvard University resolves objects as small as 20 nanometers, enabling the first ultra-resolution imaging of living biomolecules and cells. The technique, called stochastic optical reconstruction microscopy, uses glowing molecules to create high-resolution images in real-time.
The D-SPECT camera reduces image acquisition times by an order of magnitude, provides better image quality, and enables simultaneous multi-isotope imaging for more versatile diagnostics. This technology also offers personalized diagnostics taking into account patient-specific physical information.
Researchers used FLT PET to monitor treatment response in DLBCL patients treated with R-CHOP chemotherapy. Treatment led to temporary increases in FLT uptake, indicating increased DNA synthesis and tumor cell proliferation. This suggests that FLT PET may be a sensitive tool for differentiating non-responding tumors.
Researchers at UCLA have developed a new method to detect Alzheimer's disease progression using FDDNP PET. The study shows that the worsening of memory and cognitive functions is correlated with increased 18F-FDDNP brain binding, providing valuable information for diagnosis and monitoring therapeutic interventions.
Researchers found a link between increased serotonin receptors and body weight in overweight individuals. The discovery suggests that serotonin receptor manipulation could be a potential target for treating obesity.
Researchers have developed a technology that can reduce imaging time for cardiac stress/rest tests by 50% without compromising image quality. This innovation allows for increased patient comfort and improved throughput in nuclear medicine departments, enabling more patients to be scanned without additional floor space or equipment.
Gambhir, a renowned Stanford University scientist, is recognized for his extensive work in molecular imaging and basic science of using radioactive tracers. He has developed numerous methods for imaging gene/cell therapy and protein-protein interactions in living subjects.
Walter Wolf, distinguished professor of pharmaceutical sciences at USC, received the award for his groundbreaking work in pharmacokinetic imaging and radiopharmaceuticals. His research focuses on noninvasive studies of drug biodistribution and targeting using nuclear medicine imaging and magnetic resonance spectroscopy.
A new time-of-flight PET scanner with LYSO detector crystals improves diagnostic accuracy and reduces variability in patient images. This technology enables more accurate detection of small lesions and better lesion characterization, leading to improved cancer diagnosis and treatment.
Researchers have developed a non-invasive method to detect atherosclerosis by measuring coronary blood flow, allowing for early detection and treatment of high-risk patients. The study found that elevated levels of interleukin-6 are a major determinant of coronary endothelial dysfunction in individuals with hypertension.
The Society of Nuclear Medicine and Molecular Imaging (SNM) has released a landmark procedure guideline for tumor imaging with 18F-FDG PET/CT. The document provides recommendations for patient preparation, image acquisition, interpretation criteria, and quality control to ensure high-quality imaging results.
The Society of Nuclear Medicine and Molecular Imaging (SNM) has awarded $30,000 in grants to three institutions in China and India. The SNM/GE Healthcare Visiting Physician/Scientist Program Grant will cover travel and per diem costs for a one- or two-week visit to lecture, train, and consult on molecular and nuclear imaging.
Belgian and Italian researchers developed a new imaging technique that can predict breast cancer patients' response to hormonal treatment with high accuracy. The technique uses 99mTc-depreotide scintigraphy to assess hormone sensitivity in tumors, allowing for early selection of patients likely to benefit from hormonal therapy.
Researchers used molecular imaging to detect atherosclerotic plaques likely to rupture in experimental rabbit models. The study found that dietary modification and statin therapy can decrease apoptosis and stabilize plaques, supporting the paradigm of prevention over treatment for coronary artery disease.
A new programmable chip has been developed to accelerate the production of molecular imaging molecules for PET, with a 93% accuracy in detecting Alzheimer's disease. The technology enables mass production of diverse imaging molecules and applications for PET in biology and pharmaceutical research.
Researchers at Johns Hopkins University developed tiny self-assembling cube-shaped containers that can deliver medications and cells. The cubes are trackable via MRI and have shown promising results in lab tests, including the release of microbeads and live cells.
A study published in Journal of Nuclear Medicine found that PET imaging with FDG has significantly higher accuracy than genetic screening for predicting Alzheimer's disease in mild cognitive impairment (MCI) patients. Most MCI patients who showed abnormalities in their original PET scan developed dementia within 16 months.
The SNM/GE Healthcare Visiting Physician/Scientist Program Grant will provide educational enrichment in China and India through one- to two-week visits. Clinical centers, hospitals, academic institutions can apply for funding to support nuclear medicine/molecular imaging training and consulting.
Researchers at Stanford University have developed a novel 3D rendering technique for PET/CT images, allowing for simultaneous viewing of multiple modalities. This new paradigm has the potential to revolutionize diagnostic and treatment procedures for various diseases.
The new technique uses gamma camera technology to detect smaller breast lesions and improve cancer diagnosis, particularly in women with dense breast tissue. The study found a high sensitivity rate of 86% for detecting small breast tumors, outperforming conventional gamma cameras.
A study using combined positron emission tomography and computed tomography may help detect early abnormalities in the arterial wall, potentially useful for early disease detection, prevention, and prognosis. Nuclear medicine could provide valuable information on plaque composition.
The Canadian Institutes of Health Research and National Heart, Lung and Blood Institute have launched three research programs to address heart attack resuscitation, cellular imaging, and thrombotic disorders. The programs aim to improve cardiovascular disease treatment outcomes, particularly in developing countries.
Researchers have developed a new technology using firefly light to monitor herpes infections in mice, allowing for repeated tracking over time without sacrificing animals. This non-invasive method enables the investigation of viral populations and immune system influences.
Researchers at Washington University's Molecular Imaging Center are developing new applications for existing technologies like PET scans. They're also exploring new methods of molecular imaging using near-infrared fluorescence and bioluminescence probes to study protein-protein interactions, immune cells attacking tumors, and the cours...
A Yale researcher found that brain activity is consistently present in the background, contradicting cognitive theories. The study highlights the need for a more holistic approach to understanding brain function and bridging the gap between psychiatric and neuroscientific views.
A new research center at the University of Michigan will study new ways to see cancer using sophisticated medical imaging technology, including MRI and PET scans. The center aims to improve diagnosis and treatment by spotting important molecular events during cancer growth, potentially laying the groundwork for new therapies.